ES Acromegaly Guideline Summary - Guideline Central

Design and created by Guideline Central in participation with the Endocrine Society.

Document Overview

Document Title: Acromegaly

Authoring Society: Endocrine Society

Document Publication Date: Oct 31, 2014

Page Last Reviewed/Updated: Feb 12, 2026

Document Type: Guideline

Country of Publication: United States

Full Text Freely Available: Yes

Full Text Guideline: academic.oup.com/jcem/article/99/11/3933/2836347

Source Citation: Laurence Katznelson, Edward R. Laws, Jr, Shlomo Melmed, Mark E. Molitch, Mohammad Hassan Murad, Andrea Utz, John A. H. Wass, Acromegaly: An Endocrine Society Clinical Practice Guideline, The Journal of Clinical Endocrinology & Metabolism, Volume 99, Issue 11, 1 November 2014, Pages 3933–3951, https://doi.org/10.1210/jc.2014-2700

Supplemental Implementation Resources

Quick-Reference Guide

Document Scope, Criteria, and Use Cases

Document Objectives: The aim was to formulate clinical practice guidelines for acromegaly.

Scope: Assessment and Screening, Diagnosis, Management, Treatment

Diseases/Conditions (MeSH): D000172 - Acromegaly

Keywords: IGF-1, acromegaly, gigantism, growth hormones

Target Patient Population: patients with typical clinical manifestations of acromegaly

Health Care Settings: Ambulatory

Intended Users: Nurse, Nurse Practitioner, Physician, Physician Assistant

Recommendation Development Processes & Methodology

Number of Source Documents: 219

Includes peer/external review process?: Yes

Includes public comment process?: No

Methodologist involvement?: Yes

Patient involvement?: No

Includes multi-disciplinary group?: Yes

Includes systematic review?: Yes

Grades quality of strength of evidence?: Yes

Grades quality of strength of recommendation?: Yes

Discloses funding source?: Yes

Discloses conflicts of interest?: Yes

Includes benefits/harms analysis with recommendations?: No